- Home
- JANX vs SEMR Comparison
JANX vs SEMR Comparison
Compare JANX & SEMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- SEMR
- Stock Information
- Founded
- JANX 2017
- SEMR 2008
- Country
- JANX United States
- SEMR United States
- Employees
- JANX N/A
- SEMR N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- SEMR EDP Services
- Sector
- JANX Health Care
- SEMR Technology
- Exchange
- JANX Nasdaq
- SEMR Nasdaq
- Market Cap
- JANX 1.6B
- SEMR 1.5B
- IPO Year
- JANX 2021
- SEMR 2021
- Fundamental
- Price
- JANX $23.60
- SEMR $8.88
- Analyst Decision
- JANX Strong Buy
- SEMR Buy
- Analyst Count
- JANX 7
- SEMR 8
- Target Price
- JANX $94.29
- SEMR $17.00
- AVG Volume (30 Days)
- JANX 808.2K
- SEMR 983.7K
- Earning Date
- JANX 08-06-2025
- SEMR 08-04-2025
- Dividend Yield
- JANX N/A
- SEMR N/A
- EPS Growth
- JANX N/A
- SEMR N/A
- EPS
- JANX N/A
- SEMR 0.05
- Revenue
- JANX $9,336,000.00
- SEMR $396,021,000.00
- Revenue This Year
- JANX N/A
- SEMR $21.84
- Revenue Next Year
- JANX $1,470.82
- SEMR $18.46
- P/E Ratio
- JANX N/A
- SEMR $186.67
- Revenue Growth
- JANX 28.12
- SEMR 22.75
- 52 Week Low
- JANX $22.48
- SEMR $7.90
- 52 Week High
- JANX $71.71
- SEMR $18.74
- Technical
- Relative Strength Index (RSI)
- JANX 41.60
- SEMR 34.58
- Support Level
- JANX $24.45
- SEMR $8.96
- Resistance Level
- JANX $27.28
- SEMR $9.40
- Average True Range (ATR)
- JANX 1.35
- SEMR 0.36
- MACD
- JANX -0.09
- SEMR -0.12
- Stochastic Oscillator
- JANX 22.20
- SEMR 3.78
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About SEMR SEMrush Holdings Inc.
SEMrush Holdings Inc is engaged in the online visibility management software-as-a-service (SaaS) platform. Its platform utilizes data and intelligence at the core surrounded by AI-powered interconnected hubs focused on search engine optimization, paid advertising, social media management, local marketing, brand marketing, and content marketing Geographically, it generates revenues from the United States, the UK, and Others.